Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (22)

2024

  1. Toxicity of zinc oxide nanoparticles: Cellular and behavioural effects

    Chemosphere, Vol. 363

2023

  1. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

2022

  1. Extremophilic cyanobacteria from thermo-mineral springs of spas in Atlantic environments

    Systematics and Biodiversity, Vol. 20, Núm. 1, pp. 1-15

  2. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Open Forum Infectious Diseases, Vol. 9, Núm. 9

2021

  1. Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study

    Open Forum Infectious Diseases, Vol. 8, Núm. 6

  2. The role of intestinal microbiota in the colorectal carcinogenesis

    Foundations of Colorectal Cancer (Elsevier), pp. 495-512

2019

  1. HIV co-infection in HTLV-1 carriers in Spain

    Virus Research, Vol. 266, pp. 48-51

2015

  1. Current epidemiology and outcome of infective endocarditis: A multicenter, prospective, cohort study

    Medicine (United States), Vol. 94, Núm. 43

  2. Left-sided infective endocarditis in patients with liver cirrhosis

    Journal of Infection, Vol. 71, Núm. 6, pp. 627-641

2014

  1. HIV-2 and HTLV-1 infections in Spain, a non-endemic region

    AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159

2013

  1. Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes

    Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 9, pp. 1994-2002

  2. Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

    AIDS, Vol. 27, Núm. 1, pp. 81-85

2012

  1. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

    Retrovirology, Vol. 9

2010

  1. Isolation and Characterization of Potentially Pathogenic Antimicrobial-Resistant Escherichia coli Strains from Chicken and Pig Farms in Spain

    Applied and Environmental Microbiology, Vol. 76, Núm. 9, pp. 2799-2805

2008

  1. Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277

2007

  1. Infection by the type 2 human immunodeficiency virus and types 1 and 2 human lymphotropic virus in Spain

    Medicina Clinica

2006

  1. Isolation and biological characterization of HIV-1 BG intersubtype recombinants and other genetic forms circulating in Galicia, Spain

    Journal of Medical Virology, Vol. 78, Núm. 12, pp. 1520-1528

2005

  1. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients

    Journal of Medical Virology, Vol. 77, Núm. 1, pp. 23-28

2004

  1. Total HCV core antigen assay: A new marker of HCV viremia and its application during treatment of chronic hepatitis C

    Journal of Virological Methods, Vol. 120, Núm. 2, pp. 173-177

1997

  1. Restriction endonuclease analysis, DNA relatedness and phenotypic characterization of Campylobacter jejuni and Camp. coli isolates involved in food-borne disease

    Journal of Applied Microbiology, Vol. 82, Núm. 6, pp. 713-721